APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wearable Neuromodulation Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Wearable Neuromodulation Devices Market Outlook and Growth Opportunities 2026

29 December 2025194 pages

Choose your research edition.

Industry ResearchWearable Neuromodulation Devices Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Wearable Neuromodulation Devices Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Wearable Neuromodulation Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wearable Neuromodulation Devices Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Wearable Neuromodulation Devices Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Wearable Neuromodulation Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Wearable Neuromodulation Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Wearable Neuromodulation Devices market include Brainco, NeuroSky, Muse, Halo Neuroscience, Caputron, Nerivio, Magnus, Emotiv and Thync, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Wearable Neuromodulation Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Wearable Neuromodulation Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Wearable Neuromodulation Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Wearable Neuromodulation Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Wearable Neuromodulation Devices Segment by Company

Brainco

NeuroSky

Muse

Halo Neuroscience

Caputron

Nerivio

Magnus

Emotiv

Thync

Wearable Neuromodulation Devices Segment by Type

Head-mounted

Ear-mounted

Arm-mounted

Others

Wearable Neuromodulation Devices Segment by Application

Adults

Children

Wearable Neuromodulation Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Wearable Neuromodulation Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Wearable Neuromodulation Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Wearable Neuromodulation Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Wearable Neuromodulation Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Neuromodulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Neuromodulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Neuromodulation Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Wearable Neuromodulation Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Wearable Neuromodulation Devices industry.

Chapter 3: Detailed analysis of Wearable Neuromodulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Wearable Neuromodulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Wearable Neuromodulation Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Wearable Neuromodulation Devices Industry Trends Table 2. Wearable Neuromodulation Devices Industry Drivers Table 3. Wearable Neuromodulation Devices Industry Opportunities and Challenges Table 4. Wearable Neuromodulation Devices Industry Restraints Table 5. Global Wearable Neuromodulation Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Wearable Neuromodulation Devices Revenue Share by Company (2021-2026) Table 7. Global Wearable Neuromodulation Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Wearable Neuromodulation Devices Sales Volume Share by Company (2021-2026) Table 9. Global Wearable Neuromodulation Devices Average Price (USD/unit) of Company (2021-2026) Table 10. Global Wearable Neuromodulation Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Wearable Neuromodulation Devices Key Company Manufacturing Base & Headquarters Table 12. Global Wearable Neuromodulation Devices Company, Product Type & Application Table 13. Global Wearable Neuromodulation Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Wearable Neuromodulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Head-mounted Table 18. Significant Companies of Ear-mounted Table 19. Significant Companies of Arm-mounted Table 20. Significant Companies of Others Table 21. Global Wearable Neuromodulation Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Wearable Neuromodulation Devices Sales Volume by Type (2021-2026) & (k units) Table 23. Global Wearable Neuromodulation Devices Sales Volume by Type (2027-2032) & (k units) Table 24. Global Wearable Neuromodulation Devices Sales Volume Share by Type (2021-2026) Table 25. Global Wearable Neuromodulation Devices Sales Volume Share by Type (2027-2032) Table 26. Global Wearable Neuromodulation Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Wearable Neuromodulation Devices Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Wearable Neuromodulation Devices Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Wearable Neuromodulation Devices Sales Value Share by Type (2021-2026) Table 30. Global Wearable Neuromodulation Devices Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Adults Table 32. Significant Companies of Children Table 33. Global Wearable Neuromodulation Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Wearable Neuromodulation Devices Sales Volume by Application (2021-2026) & (k units) Table 35. Global Wearable Neuromodulation Devices Sales Volume by Application (2027-2032) & (k units) Table 36. Global Wearable Neuromodulation Devices Sales Volume Share by Application (2021-2026) Table 37. Global Wearable Neuromodulation Devices Sales Volume Share by Application (2027-2032) Table 38. Global Wearable Neuromodulation Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Wearable Neuromodulation Devices Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Wearable Neuromodulation Devices Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Wearable Neuromodulation Devices Sales Value Share by Application (2021-2026) Table 42. Global Wearable Neuromodulation Devices Sales Value Share by Application (2027-2032) Table 43. Global Wearable Neuromodulation Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Wearable Neuromodulation Devices Sales by Region (2021-2026) & (k units) Table 45. Global Wearable Neuromodulation Devices Sales Market Share by Region (2021-2026) Table 46. Global Wearable Neuromodulation Devices Sales by Region (2027-2032) & (k units) Table 47. Global Wearable Neuromodulation Devices Sales Market Share by Region (2027-2032) Table 48. Global Wearable Neuromodulation Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Wearable Neuromodulation Devices Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Wearable Neuromodulation Devices Sales Value Share by Region (2021-2026) Table 51. Global Wearable Neuromodulation Devices Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Wearable Neuromodulation Devices Sales Value Share by Region (2027-2032) Table 53. Global Wearable Neuromodulation Devices Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Wearable Neuromodulation Devices Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Wearable Neuromodulation Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Wearable Neuromodulation Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 58. Global Wearable Neuromodulation Devices Sales Market Share by Country (2021-2026) Table 59. Global Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 60. Global Wearable Neuromodulation Devices Sales Market Share by Country (2027-2032) Table 61. Global Wearable Neuromodulation Devices Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Wearable Neuromodulation Devices Sales Value Market Share by Country (2021-2026) Table 63. Global Wearable Neuromodulation Devices Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Wearable Neuromodulation Devices Sales Value Market Share by Country (2027-2032) Table 65. Brainco Company Information Table 66. Brainco Business Overview Table 67. Brainco Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Brainco Wearable Neuromodulation Devices Product Portfolio Table 69. Brainco Recent Development Table 70. NeuroSky Company Information Table 71. NeuroSky Business Overview Table 72. NeuroSky Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. NeuroSky Wearable Neuromodulation Devices Product Portfolio Table 74. NeuroSky Recent Development Table 75. Muse Company Information Table 76. Muse Business Overview Table 77. Muse Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Muse Wearable Neuromodulation Devices Product Portfolio Table 79. Muse Recent Development Table 80. Halo Neuroscience Company Information Table 81. Halo Neuroscience Business Overview Table 82. Halo Neuroscience Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio Table 84. Halo Neuroscience Recent Development Table 85. Caputron Company Information Table 86. Caputron Business Overview Table 87. Caputron Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Caputron Wearable Neuromodulation Devices Product Portfolio Table 89. Caputron Recent Development Table 90. Nerivio Company Information Table 91. Nerivio Business Overview Table 92. Nerivio Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Nerivio Wearable Neuromodulation Devices Product Portfolio Table 94. Nerivio Recent Development Table 95. Magnus Company Information Table 96. Magnus Business Overview Table 97. Magnus Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Magnus Wearable Neuromodulation Devices Product Portfolio Table 99. Magnus Recent Development Table 100. Emotiv Company Information Table 101. Emotiv Business Overview Table 102. Emotiv Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Emotiv Wearable Neuromodulation Devices Product Portfolio Table 104. Emotiv Recent Development Table 105. Thync Company Information Table 106. Thync Business Overview Table 107. Thync Wearable Neuromodulation Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Thync Wearable Neuromodulation Devices Product Portfolio Table 109. Thync Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Wearable Neuromodulation Devices Distributors List Table 113. Wearable Neuromodulation Devices Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Wearable Neuromodulation Devices Product Image Figure 2. Global Wearable Neuromodulation Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wearable Neuromodulation Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Wearable Neuromodulation Devices Sales (2021-2032) & (k units) Figure 5. Global Wearable Neuromodulation Devices Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Wearable Neuromodulation Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Head-mounted Image Figure 10. Ear-mounted Image Figure 11. Arm-mounted Image Figure 12. Others Image Figure 13. Global Wearable Neuromodulation Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Wearable Neuromodulation Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Wearable Neuromodulation Devices Sales Volume Share by Type (2021-2032) Figure 16. Global Wearable Neuromodulation Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Wearable Neuromodulation Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Wearable Neuromodulation Devices Sales Value Share by Type (2021-2032) Figure 19. Adults Image Figure 20. Children Image Figure 21. Global Wearable Neuromodulation Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Wearable Neuromodulation Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Wearable Neuromodulation Devices Sales Volume Share by Application (2021-2032) Figure 24. Global Wearable Neuromodulation Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Wearable Neuromodulation Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Wearable Neuromodulation Devices Sales Value Share by Application (2021-2032) Figure 27. Global Wearable Neuromodulation Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Wearable Neuromodulation Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Wearable Neuromodulation Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Wearable Neuromodulation Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Wearable Neuromodulation Devices Sales Value (2021-2032) & (US$ Million) Figure 32. North America Wearable Neuromodulation Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Wearable Neuromodulation Devices Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Wearable Neuromodulation Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Wearable Neuromodulation Devices Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Wearable Neuromodulation Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Wearable Neuromodulation Devices Sales Value (2021-2032) & (US$ Million) Figure 38. South America Wearable Neuromodulation Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Wearable Neuromodulation Devices Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Wearable Neuromodulation Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Wearable Neuromodulation Devices Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Wearable Neuromodulation Devices Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Head-mounted
  • Ear-mounted
  • Arm-mounted
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Brainco
  • NeuroSky
  • Muse
  • Halo Neuroscience
  • Caputron
  • Nerivio
  • Magnus
  • Emotiv
  • Thync

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Wearable Neuromodulation Devices Sales Value (2021-2032)
  4. 1.2.2 Global Wearable Neuromodulation Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Wearable Neuromodulation Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Wearable Neuromodulation Devices Market Dynamics
  1. 2.1 Wearable Neuromodulation Devices Industry Trends
  2. 2.2 Wearable Neuromodulation Devices Industry Drivers
  3. 2.3 Wearable Neuromodulation Devices Industry Opportunities and Challenges
  4. 2.4 Wearable Neuromodulation Devices Industry Restraints
3 Wearable Neuromodulation Devices Market by Company
  1. 3.1 Global Wearable Neuromodulation Devices Company Revenue Ranking in 2025
  2. 3.2 Global Wearable Neuromodulation Devices Revenue by Company (2021-2026)
  3. 3.3 Global Wearable Neuromodulation Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Wearable Neuromodulation Devices Average Price by Company (2021-2026)
  5. 3.5 Global Wearable Neuromodulation Devices Company Ranking (2024-2026)
  6. 3.6 Global Wearable Neuromodulation Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Wearable Neuromodulation Devices Company Product Type and Application
  8. 3.8 Global Wearable Neuromodulation Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Wearable Neuromodulation Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Wearable Neuromodulation Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Wearable Neuromodulation Devices Market by Type
  1. 4.1 Wearable Neuromodulation Devices Type Introduction
  2. 4.1.1 Head-mounted
  3. 4.1.2 Ear-mounted
  4. 4.1.3 Arm-mounted
  5. 4.1.4 Others
  6. 4.2 Global Wearable Neuromodulation Devices Sales Volume by Type
  7. 4.2.1 Global Wearable Neuromodulation Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Wearable Neuromodulation Devices Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Wearable Neuromodulation Devices Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Wearable Neuromodulation Devices Sales Value by Type
  11. 4.3.1 Global Wearable Neuromodulation Devices Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Wearable Neuromodulation Devices Sales Value by Type (2021-2032)
  13. 4.3.3 Global Wearable Neuromodulation Devices Sales Value Share by Type (2021-2032)
5 Wearable Neuromodulation Devices Market by Application
  1. 5.1 Wearable Neuromodulation Devices Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Wearable Neuromodulation Devices Sales Volume by Application
  5. 5.2.1 Global Wearable Neuromodulation Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Wearable Neuromodulation Devices Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Wearable Neuromodulation Devices Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Wearable Neuromodulation Devices Sales Value by Application
  9. 5.3.1 Global Wearable Neuromodulation Devices Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Wearable Neuromodulation Devices Sales Value by Application (2021-2032)
  11. 5.3.3 Global Wearable Neuromodulation Devices Sales Value Share by Application (2021-2032)
6 Wearable Neuromodulation Devices Regional Sales and Value Analysis
  1. 6.1 Global Wearable Neuromodulation Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Wearable Neuromodulation Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Wearable Neuromodulation Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Wearable Neuromodulation Devices Sales by Region (2027-2032)
  5. 6.3 Global Wearable Neuromodulation Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Wearable Neuromodulation Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Wearable Neuromodulation Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Wearable Neuromodulation Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Wearable Neuromodulation Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Wearable Neuromodulation Devices Sales Value (2021-2032)
  12. 6.6.2 North America Wearable Neuromodulation Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Wearable Neuromodulation Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Wearable Neuromodulation Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Wearable Neuromodulation Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Wearable Neuromodulation Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Wearable Neuromodulation Devices Sales Value (2021-2032)
  21. 6.9.2 South America Wearable Neuromodulation Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Wearable Neuromodulation Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Wearable Neuromodulation Devices Sales Value Share by Country, 2025 VS 2032
7 Wearable Neuromodulation Devices Country-level Sales and Value Analysis
  1. 7.1 Global Wearable Neuromodulation Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Wearable Neuromodulation Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Wearable Neuromodulation Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Wearable Neuromodulation Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Wearable Neuromodulation Devices Sales by Country (2027-2032)
  6. 7.4 Global Wearable Neuromodulation Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Wearable Neuromodulation Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Wearable Neuromodulation Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Wearable Neuromodulation Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Wearable Neuromodulation Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Wearable Neuromodulation Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Brainco
  2. 8.1.1 Brainco Company Information
  3. 8.1.2 Brainco Business Overview
  4. 8.1.3 Brainco Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Brainco Wearable Neuromodulation Devices Product Portfolio
  6. 8.1.5 Brainco Recent Developments
  7. 8.2 NeuroSky
  8. 8.2.1 NeuroSky Company Information
  9. 8.2.2 NeuroSky Business Overview
  10. 8.2.3 NeuroSky Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 NeuroSky Wearable Neuromodulation Devices Product Portfolio
  12. 8.2.5 NeuroSky Recent Developments
  13. 8.3 Muse
  14. 8.3.1 Muse Company Information
  15. 8.3.2 Muse Business Overview
  16. 8.3.3 Muse Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Muse Wearable Neuromodulation Devices Product Portfolio
  18. 8.3.5 Muse Recent Developments
  19. 8.4 Halo Neuroscience
  20. 8.4.1 Halo Neuroscience Company Information
  21. 8.4.2 Halo Neuroscience Business Overview
  22. 8.4.3 Halo Neuroscience Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio
  24. 8.4.5 Halo Neuroscience Recent Developments
  25. 8.5 Caputron
  26. 8.5.1 Caputron Company Information
  27. 8.5.2 Caputron Business Overview
  28. 8.5.3 Caputron Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Caputron Wearable Neuromodulation Devices Product Portfolio
  30. 8.5.5 Caputron Recent Developments
  31. 8.6 Nerivio
  32. 8.6.1 Nerivio Company Information
  33. 8.6.2 Nerivio Business Overview
  34. 8.6.3 Nerivio Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nerivio Wearable Neuromodulation Devices Product Portfolio
  36. 8.6.5 Nerivio Recent Developments
  37. 8.7 Magnus
  38. 8.7.1 Magnus Company Information
  39. 8.7.2 Magnus Business Overview
  40. 8.7.3 Magnus Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Magnus Wearable Neuromodulation Devices Product Portfolio
  42. 8.7.5 Magnus Recent Developments
  43. 8.8 Emotiv
  44. 8.8.1 Emotiv Company Information
  45. 8.8.2 Emotiv Business Overview
  46. 8.8.3 Emotiv Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Emotiv Wearable Neuromodulation Devices Product Portfolio
  48. 8.8.5 Emotiv Recent Developments
  49. 8.9 Thync
  50. 8.9.1 Thync Company Information
  51. 8.9.2 Thync Business Overview
  52. 8.9.3 Thync Wearable Neuromodulation Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Thync Wearable Neuromodulation Devices Product Portfolio
  54. 8.9.5 Thync Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Wearable Neuromodulation Devices Value Chain Analysis
  2. 9.1.1 Wearable Neuromodulation Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Wearable Neuromodulation Devices Sales Mode & Process
  6. 9.2 Wearable Neuromodulation Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Wearable Neuromodulation Devices Distributors
  9. 9.2.3 Wearable Neuromodulation Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst